Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18 - 50
Code: NCT07079839
Recruiting
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
for
Advanced Alveolar Soft Part Sarcoma,
Location: Houston TX, Oklahoma City OK, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05333458
Phase 2, Recruiting
Evaluation of Cataract Surgery Outcomes in Patients With Prior Laser Vision Correction Implanted With the CT LUCIA Lens
for
Postoperative Visual Outcomes Following Cataract Surgery in Patients With Prior Myopic Corneal Laser Vision Correction,
Location: Sugar Land TX, Lynchburg VA
Sponsor: Carl Zeiss Meditec AG
Sex: All
Age: 18+
Code: NCT07084545
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Houston TX, Round Rock TX, Baton Rouge LA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase 3, Recruiting
North American Fetal Therapy Network for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia
for
Congenital Diaphragmatic Hernia
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: Female
Age: 18+
Code: NCT06739356
Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation